13F-HR filed by Ghost Tree Capital, LLC
Ghost Tree Capital, LLC filed this 13F-HR for the quarter ended 2020-09-30, filed 2020-11-16, with 46 holding rows worth $345,988,000.
- Accession
- 0001387131-20-009944
- Filer
- CIK 1595851
- Filed
- 2020-11-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2020
A holdings report, 47 entries on the cover page, a total value of $345,988,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $345,988,000 with VALUE read as thousands by filing date, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 451,000 | $50,255,000 | thousands by filing date | put |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 1,950,000 | $27,710,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 130,000 | $20,062,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 1,050,000 | $19,551,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 575,000 | $18,929,000 | thousands by filing date | |
| IMMUNOVANT INC | 45258J102 | COM | 525,000 | $18,475,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 725,000 | $14,689,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 1,161,375 | $11,962,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 60,000 | $9,963,000 | thousands by filing date | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 1,250,000 | $9,263,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 400,000 | $9,144,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 65,000 | $9,128,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 600,000 | $8,472,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 550,000 | $8,102,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 200,000 | $7,994,000 | thousands by filing date | |
| SURFACE ONCOLOGY INC | 86877M209 | COM | 1,000,000 | $6,900,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 225,000 | $6,894,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 1,950,000 | $6,698,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 425,000 | $6,273,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 175,000 | $6,125,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 1,000,000 | $5,640,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 200,000 | $5,352,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 805,556 | $5,027,000 | thousands by filing date | |
| IMMUNIC INC | 4525EP101 | COM | 265,000 | $4,921,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 200,000 | $4,722,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 350,000 | $4,407,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 825,000 | $4,158,000 | thousands by filing date | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 115,000 | $3,703,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 425,000 | $3,608,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 325,000 | $3,598,000 | thousands by filing date | |
| NEXTCURE INC | 65343E108 | COM | 400,000 | $3,520,000 | thousands by filing date | |
| MYOVANT SCIENCES LTD | G637AM102 | COMMON STOCK-FO | 250,000 | $3,513,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 30,000 | $2,923,000 | thousands by filing date | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 200,000 | $2,640,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 75,000 | $2,064,000 | thousands by filing date | |
| MILLENDO THERAPEUTICS INC | 60040X103 | COM | 925,000 | $1,508,000 | thousands by filing date | |
| TRANSPORTATION & LOGISTI | 438083107 | COM | 135,000 | $1,445,000 | thousands by filing date | |
| IMV INC | 44974L103 | COM | 325,000 | $1,443,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 4,200 | $1,191,000 | thousands by filing date | |
| GRAYBUG VISION INC COM | 38942Q103 | SHS | 75,000 | $953,000 | thousands by filing date | |
| SATSUMA PHARMACEUTICALS INC | 80405P107 | COM | 200,000 | $778,000 | thousands by filing date | |
| MODERNA INC | 60770K107 | COM | 10,000 | $708,000 | thousands by filing date | |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 250,000 | $628,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 100,000 | $421,000 | thousands by filing date | |
| BRISTOL-MYERS SQUIBB CO | 110122157 | RIGHT 99/99/9999 | 125,000 | $281,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 4,500 | $247,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001387131-20-009944 | this filing | 2020-11-16 | acceptance time not in the bulk data set |